» Articles » PMID: 23483283

Intrahepatic Left to Right Portoportal Venous Collateral Vascular Formation in Patients Undergoing Right Portal Vein Ligation

Overview
Date 2013 Mar 14
PMID 23483283
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We investigated intrahepatic vascular changes in patients undergoing right portal vein ligation (PVL) or portal vein embolization (PVE) in conjunction with the ensuing hypertrophic response and function of the left liver lobe.

Methods: Between December 2008 and October 2011, 7 patients underwent right PVL and 14 patients PVE. Computed tomographic (CT) volumetry to assess future remnant liver (FRL) and functional hepatobiliary scintigraphy were performed in all patients before and 3 weeks after portal vein occlusion. In 18 patients an intraoperative portography was performed to assess perfusion through the occluded portal branches.

Results: In all patients after initially successful PVL, reperfused portal veins were observed on CT scan 3 weeks after portal occlusion. This was confirmed in all cases during intraoperative portography. Intrahepatic portoportal collaterals were identified in all patients in the PVL group and in one patient in the PVE group. In all other PVE patients, complete occlusion of the embolized portal branches was observed on CT scan and on intraoperative portography. The median increase of FRL volume after PVE was 41.6 % (range 10-305 %), and after PVL was only 8.1 % (range 0-102 %) (p = 0.179). There were no differences in FRL function between both groups.

Conclusion: Preoperative PVE and PVL are both methods to induce hypertrophy of the FRL in anticipation of major liver resection. Compared to PVE, PVL seems less efficient in inducing hypertrophy of the nonoccluded left lobe. This could be caused by the formation of intrahepatic portoportal neocollateral vessels, through which the ligated portal branches are reperfused within 3 weeks.

Citing Articles

Circulating proliferative factors versus portal inflow redistribution: mechanistic insights of ALPPS-derived rapid liver regeneration.

Zhang S, Ma Y, Chen X, Wu S, Chen G Front Oncol. 2025; 14():1429564.

PMID: 39839786 PMC: 11747645. DOI: 10.3389/fonc.2024.1429564.


Use of indocyanine green-human serum albumin complexes in fluorescence image-guided laparoscopic anatomical liver resection: a case series study (with video).

Gao F, Xie Q, Ran X, Zhao X, Yang M, Jiang K Surg Endosc. 2024; 38(11):6938-6947.

PMID: 39342539 PMC: 11525420. DOI: 10.1007/s00464-024-11295-8.


Right portal vein ligation is still relevant for left hemi-liver hypertrophy: results of a comparative study using a propensity score between right portal vein ligation and embolization.

Werey F, Dembinski J, Michaud A, Sabbagh C, Mauvais F, Yzet T Langenbecks Arch Surg. 2023; 409(1):25.

PMID: 38158401 DOI: 10.1007/s00423-023-03213-8.


Comparison of clinical efficacy between LAPS and ALPPS in the treatment of hepatitis B virus-related hepatocellular carcinoma.

Chen Z, Shen S, Xie W, Liao J, Feng S, Li S Gastroenterol Rep (Oxf). 2023; 11:goad060.

PMID: 37842201 PMC: 10570994. DOI: 10.1093/gastro/goad060.


Efficacy and safety of different options for liver regeneration of future liver remnant in patients with liver malignancies: a systematic review and network meta-analysis.

Yi F, Zhang W, Feng L World J Surg Oncol. 2022; 20(1):399.

PMID: 36527081 PMC: 9756618. DOI: 10.1186/s12957-022-02867-w.